[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
TISSUE=Pancreas, and Pancreatic cancer;
DOI=10.1038/sj.onc.1201110; PubMed=9178771 [NCBI, ExPASy, EBI, Israel, Japan]
Mueller-Pillasch F.,
Lacher U.,
Wallrapp C.,
Micha A.,
Zimmerhackl F.,
Hameister H.,
Varga G.,
Friess H.,
Buechler M.,
Beger H.G.,
Vila M.R.,
Adler G.,
Gress T.M.;
"Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein.";
Oncogene 14:2729-2733(1997).
|
[2]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Endometrial tumor;
DOI=10.1186/1471-2164-8-399; PubMed=17974005 [NCBI, ExPASy, EBI, Israel, Japan]
Bechtel S.,
Rosenfelder H.,
Duda A.,
Schmidt C.P.,
Ernst U.,
Wellenreuther R.,
Mehrle A.,
Schuster C.,
Bahr A.,
Blocker H.,
Heubner D.,
Hoerlein A.,
Michel G.,
Wedler H.,
Kohrer K.,
Ottenwalder B.,
Poustka A.,
Wiemann S.,
Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
TISSUE=Eye, and Lymph;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[4]
|
TISSUE SPECIFICITY.
DOI=10.1016/S0925-4773(99)00160-4; PubMed=10525192 [NCBI, ExPASy, EBI, Israel, Japan]
Mueller-Pillasch F.,
Pohl B.,
Wilda M.,
Lacher U.,
Beil M.,
Wallrapp C.,
Hameister H.,
Knoechel W.,
Adler G.,
Gress T.M.;
"Expression of the highly conserved RNA binding protein KOC in embryogenesis.";
Mech. Dev. 88:95-99(1999).
|
[5]
|
GENE FAMILY NOMENCLATURE, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND RNA-BINDING.
PubMed=9891060 [NCBI, ExPASy, EBI, Israel, Japan]
Nielsen J.,
Christiansen J.,
Lykke-Andersen J.,
Johnsen A.H.,
Wewer U.M.,
Nielsen F.C.;
"A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.";
Mol. Cell. Biol. 19:1262-1270(1999).
|
[6]
|
IDENTIFICATION AS A CARCINOMA ANTIGEN.
DOI=10.1006/clim.2001.5048; PubMed=11465943 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang J.-Y.,
Chan E.K.,
Peng X.-X.,
Lu M.,
Wang X.,
Mueller F.,
Tan E.M.;
"Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies.";
Clin. Immunol. 100:149-156(2001).
|
[7]
|
TISSUE SPECIFICITY.
DOI=10.1136/jmg.39.8.575; PubMed=12161597 [NCBI, ExPASy, EBI, Israel, Japan]
Monk D.,
Bentley L.,
Beechey C.,
Hitchins M.,
Peters J.,
Preece M.A.,
Stanier P.,
Moore G.E.;
"Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome.";
J. Med. Genet. 39:575-581(2002).
|
[8]
|
SUBCELLULAR LOCATION.
DOI=10.1042/BJ20030943; PubMed=12921532 [NCBI, ExPASy, EBI, Israel, Japan]
Nielsen J.,
Adolph S.K.,
Rajpert-De Meyts E.,
Lykke-Andersen J.,
Koch G.,
Christiansen J.,
Nielsen F.C.;
"Nuclear transit of human zipcode-binding protein IMP1.";
Biochem. J. 376:383-391(2003).
|
[9]
|
REVIEW.
DOI=10.1042/BC20040151; PubMed=15601260 [NCBI, ExPASy, EBI, Israel, Japan]
Yisraeli J.K.;
"VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins.";
Biol. Cell 97:87-96(2005).
|
[10]
|
SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
DOI=10.1097/01.pas.0000149688.98333.54; PubMed=15644775 [NCBI, ExPASy, EBI, Israel, Japan]
Yantiss R.K.,
Woda B.A.,
Fanger G.R.,
Kalos M.,
Whalen G.F.,
Tada H.,
Andersen D.K.,
Rock K.L.,
Dresser K.;
"KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.";
Diagn. Mol. Pathol. 29:188-195(2005).
|
[11]
|
SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
DOI=10.1530/rep.1.00664; PubMed=16049158 [NCBI, ExPASy, EBI, Israel, Japan]
Hammer N.A.,
Hansen T.O.,
Byskov A.G.,
Rajpert-De Meyts E.,
Groendahl M.L.,
Bredkjaer H.E.,
Wewer U.M.,
Christiansen J.,
Nielsen F.C.;
"Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer.";
Reproduction 130:203-212(2005).
|
[12]
|
FUNCTION, RNA-BINDING, AND SUBCELLULAR LOCATION.
DOI=10.1038/sj.emboj.7601039; PubMed=16541107 [NCBI, ExPASy, EBI, Israel, Japan]
Vikesaa J.,
Hansen T.V.,
Joenson L.,
Borup R.,
Wewer U.M.,
Christiansen J.,
Nielsen F.C.;
"RNA-binding IMPs promote cell adhesion and invadopodia formation.";
EMBO J. 25:1456-1468(2006).
|
[13]
|
SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
DOI=10.1016/S1470-2045(06)70732-X; PubMed=16814207 [NCBI, ExPASy, EBI, Israel, Japan]
Jiang Z.,
Chu P.G.,
Woda B.A.,
Rock K.L.,
Liu Q.,
Hsieh C.-C.,
Li C.,
Chen W.,
Duan H.O.,
McDougal S.,
Wu C.-L.;
"Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.";
Lancet Oncol. 7:556-564(2006).
|
[14]
|
SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
DOI=10.1038/modpathol.3800735; PubMed=17192788 [NCBI, ExPASy, EBI, Israel, Japan]
Li C.,
Rock K.L.,
Woda B.A.,
Jiang Z.,
Fraire A.E.,
Dresser K.;
"IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.";
Mod. Pathol. 20:242-247(2007).
|
[15]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-528, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0805139105; PubMed=18669648 [NCBI, ExPASy, EBI, Israel, Japan]
Dephoure N.,
Zhou C.,
Villen J.,
Beausoleil S.A.,
Bakalarski C.E.,
Elledge S.J.,
Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
|
[16]
|
IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
Colinge J.,
Superti-Furga G.,
Bennett K.L.;
Submitted (OCT-2008) to UniProtKB.
|
[17]
|
STRUCTURE BY NMR OF 73-161.
RIKEN structural genomics initiative (RSGI);
"Solution structure of RNA binding domain in insulin-like growth factor 2 mRNA-binding protein 3.";
Submitted (JUN-2007) to the PDB data bank.
|
|
ExPASy Home page
SIB Switzerland
